Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Personalized medication for overactive bladder with imidafenacin treatment

Trial Profile

Personalized medication for overactive bladder with imidafenacin treatment

Recruiting
Phase of Trial: Phase II

Latest Information Update: 08 Jan 2018

At a glance

  • Drugs Imidafenacin (Primary)
  • Indications Overactive bladder
  • Focus Therapeutic Use
  • Acronyms PERMIT study
  • Most Recent Events

    • 05 Jan 2018 Status changed from not yet recruiting to recruiting.
    • 16 Mar 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top